RxDoctor Payments DataLook up a doctor →

Michael Phillips, MD

Family Medicine · Ruston, LANPI 1154391431

Payments from drug & device makers

$16,228in general payments, 2019–2025

Across 1,012 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Lilly USA, LLC$1K
  • Bayer$894
  • Pfizer$797
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)83$1,648
Novo Nordisk96$1,507
Takeda Pharmaceuticals U.S.A., Inc.81$1,260
Lilly USA, LLC88$1,169
Bayer52$894
Pfizer55$797
Amgen49$769
Boehringer Ingelheim48$760
AbbVie(2 entities)56$677
GSK34$620
Acadia Pharmaceuticals Inc54$579
Merck34$525
Astellas Pharma US Inc24$383
Sumitomo Pharma America, Inc.25$381
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$334
Otsuka America Pharmaceutical, Inc.15$307
Phathom Pharmaceuticals, Inc.14$245
Lundbeck LLC12$232
Kowa Pharmaceuticals America, Inc.15$223
Biohaven Pharmaceutical Holding Company Ltd.10$222
Supernus Pharmaceuticals, Inc.5$211
Esperion Therapeutics, Inc.14$198
Biohaven Pharmaceuticals, Inc.10$170
Ironshore Pharmaceuticals Inc.8$170
Johnson & Johnson10$153
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$135
Idorsia Pharmaceuticals US Inc7$120
Axsome Therapeutics, Inc.5$111
Teva Pharmaceuticals USA, Inc.8$101
Abbott4$82
Sunovion Pharmaceuticals Inc.8$77
Sanofi1$76
Stryker1$73
Collegium Pharmaceutical, Inc.4$70
Shire North American Group Inc3$61
Vanda Pharmaceuticals Inc.3$60
Mannkind Corporation1$59
Amarin Pharma, Inc.4$56
Exact Sciences3$49
Dexcom, Inc.2$48
Novartis3$47
Ardelyx, Inc.2$43
Avanir Pharmaceuticals, Inc.2$40
IBSA Pharma Inc.2$40
Boston Scientific2$39
Tris Pharma Inc2$39
Xeris Pharmaceuticals, Inc.2$37
Eisai Inc.2$36
Corcept Therapeutics2$34
Corium, LLC4$33
Mylan Specialty L.p.1$28
Abiomed1$22
Kyowa Kirin, Inc.1$21
Inspire Medical Systems, Inc.1$20
Sanofi-aventis U.S. LLC1$19
Jazz Pharmaceuticals Inc.1$18
Ironwood Pharmaceuticals, Inc1$16
Genentech USA, Inc.1$16
Philips North America LLC1$15
Adlon Therapeutics L.p.1$14

How this compares

$16,228 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$246,945
Medicare patients
733
Services billed
4,912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Ruston

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →